Clinical Trial Results:
Untersuchung des Einflusses von Carbamazepin auf die mittels transkranieller Magnetstimulation gemessene kortikale Exzitabilität des menschlichen Motorkortex in Abhängigkeit vom Polymorphismus für SCN1A
Differential effect of Carbamazepine on cortical excitability in subjects with different genotypes for SCN1A as measured by transcranial magnetic stimulation (TMS)
Summary
|
|
EudraCT number |
2008-003392-40 |
Trial protocol |
DE |
Global completion date |
17 Jan 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Nov 2020
|
First version publication date |
06 Nov 2020
|
Other versions |
|
Summary report(s) |
E3-synopsis Epicure |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.